Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!
- PMID: 7635798
- DOI: 10.1016/0360-3016(95)00262-W
Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!
Comment in
-
In response to Bentzen et al., IJROBP 32:1531-1534; 1995.Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1547. doi: 10.1016/0360-3016(95)99002-W. Int J Radiat Oncol Biol Phys. 1995. PMID: 7635803 No abstract available.
-
Regarding actuarial late effect analyses: Bentzen et al., IJROBP 32:1531-1534; 1995 and Caplan et al., IJROBP 32:1547; 1995.Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):197. doi: 10.1016/s0360-3016(96)85032-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8641920 No abstract available.
-
Re: Caplan et al. IJROBP 29:1183-1186; 1994, and Bentzen et al. IJROBP 32:1531-1534; 1995.Int J Radiat Oncol Biol Phys. 1996 Nov 1;36(4):988-9. doi: 10.1016/s0360-3016(97)89873-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8960538 No abstract available.
-
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):563. doi: 10.1016/s0360-3016(01)01661-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11579925 No abstract available.
Comment on
-
Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix.Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1289-300. doi: 10.1016/0360-3016(95)00118-I. Int J Radiat Oncol Biol Phys. 1995. PMID: 7635768
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources